Login

alone_universe

It's About the Community! 2012
06-08-2012 06:00 PM
Category: 2012 Events

Effect of Hepatic Impairment on the Pharmacokinetics of Pasireotide (SOM230): Results From a Multicenter Phase I Study.
MedWorm: Acromegaly 25 Jan 2012 | 10:00 pm
In conclusion, a single dose of pasireotide SC 600 Âµg was well tolerated in subjects with hepatic impairment. Drug exposure[…]
Read more...